Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
MaxCyte ( (MXCT) ) has issued an announcement.
MaxCyte, Inc., a non-UK issuer, has announced a significant change in its voting rights structure due to an acquisition or disposal of voting rights and financial instruments by BlackRock, Inc. The notification indicates that BlackRock’s total voting rights in MaxCyte have increased to 9.12%, up from a previous 8.24%. This change reflects BlackRock’s strategic positioning and influence within MaxCyte, potentially impacting the company’s governance and stakeholder interests.
More about MaxCyte
Learn more about MXCT stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue